Austin, TX: Republican Gov. Greg Abbott has signed legislation into law expanding the pool of patents eligible to receive low-THC/high-CBD medical cannabis products.
House Bill 3703 permits those patients diagnosed with autism, amyotrophic lateral sclerosis (aka Lou Gehrig’s disease), multiple sclerosis, seizure disorders, incurable neurodegenerative disorders and/or terminal cancer to be eligible to register in the state’s limited cannabis access program. The measure also removes the requirement that patients obtain recommendations from two participating physicians prior to enrolling in the program.
The new law takes effect on September 1, 2019.
For more information, contact Carly Wolf, NORML State Policies Coordinator, at (202) 483-5500 or visit Texas NORML.